P7 THE URINARY PEPTIDOMIC SIGNATURE OF AORTIC STIFFNESS REVEALS MOLECULAR PATHWAYS AND DRUG TARGETS
Background: Molecular pathways leading to stiffening of the central arteries are poorly understood. We searched for differentially expressed proteins by urinary peptidomic analysis in patients with arterial stiffness and healthy controls in a case–control study. Methods: To identify urinary peptide...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2017-12-01
|
| Series: | Artery Research |
| Online Access: | https://www.atlantis-press.com/article/125930242/view |
| _version_ | 1818572343830642688 |
|---|---|
| author | Zhen-Yu Zhang Makis Izoidakis Wen-Yi Yang Lutgarde Thijs Fang-Fei Wei Qi-Fang Huang Joost Schanstra Jens-Uwe Voigt Tatiana Kuznetsova Peter Verhamme Antonia Vlahou Harald Mischak Jan Staessen |
| author_facet | Zhen-Yu Zhang Makis Izoidakis Wen-Yi Yang Lutgarde Thijs Fang-Fei Wei Qi-Fang Huang Joost Schanstra Jens-Uwe Voigt Tatiana Kuznetsova Peter Verhamme Antonia Vlahou Harald Mischak Jan Staessen |
| author_sort | Zhen-Yu Zhang |
| collection | DOAJ |
| description | Background: Molecular pathways leading to stiffening of the central arteries are poorly understood. We searched for differentially expressed proteins by urinary peptidomic analysis in patients with arterial stiffness and healthy controls in a case–control study.
Methods: To identify urinary peptides associated with aortic stiffening, we applied capillary electrophoresis coupled to mass spectrometry. We compared 18 cardiovarscular disease-free patients with carotid-femoral pulse wave velocity (PWV > 10 m/s standardised to a heart rate of 75/minute as measured by the SphygmoCor method) with 18 controls matched for sex, age and mean arterial pressure.
Results: 69 urinary peptides had a different signal amplitude between cases and controls (P ≤ 0.049). Among 33 peptides with known sequence, 26 were members of the extracellular matrix family, including collagen type I α-1 and α-2, collagen type III α-1, collagen type IV α-5, collagens IX, XXI and XXVII. Collagen type I was down-regulated, whereas collagen type III was up-regulated. Epidermal growth factor receptor (EGFR), a key regulator of myoblast differentiation, and interactions of laminin with other proteins were down-regulated. Atherosclerosis signalling pathways and intrinsic prothrombin activation were the top pathways associated with increased PWV. Potential drug targets included collagen type IV α 3 and transforming growth factor β 3. Angiotensin-converting enzyme inhibitors, which are widely used for vascular protection, were among the possible therapeutic agents.
Conclusions: We suggest that stiffening of large elastic arteries involves changes of the extracellular matrix, as reflected by collagen turnover and regulation of myoblast differentiation. Pathway analysis identified potential drug targets, possibly amenable by angiotensin-converting enzyme inhibition. |
| first_indexed | 2024-12-14T18:55:51Z |
| format | Article |
| id | doaj.art-b7ac63d167e54513a94222479ed4b729 |
| institution | Directory Open Access Journal |
| issn | 1876-4401 |
| language | English |
| last_indexed | 2024-12-14T18:55:51Z |
| publishDate | 2017-12-01 |
| publisher | BMC |
| record_format | Article |
| series | Artery Research |
| spelling | doaj.art-b7ac63d167e54513a94222479ed4b7292022-12-21T22:51:06ZengBMCArtery Research1876-44012017-12-012010.1016/j.artres.2017.10.060P7 THE URINARY PEPTIDOMIC SIGNATURE OF AORTIC STIFFNESS REVEALS MOLECULAR PATHWAYS AND DRUG TARGETSZhen-Yu ZhangMakis IzoidakisWen-Yi YangLutgarde ThijsFang-Fei WeiQi-Fang HuangJoost SchanstraJens-Uwe VoigtTatiana KuznetsovaPeter VerhammeAntonia VlahouHarald MischakJan StaessenBackground: Molecular pathways leading to stiffening of the central arteries are poorly understood. We searched for differentially expressed proteins by urinary peptidomic analysis in patients with arterial stiffness and healthy controls in a case–control study. Methods: To identify urinary peptides associated with aortic stiffening, we applied capillary electrophoresis coupled to mass spectrometry. We compared 18 cardiovarscular disease-free patients with carotid-femoral pulse wave velocity (PWV > 10 m/s standardised to a heart rate of 75/minute as measured by the SphygmoCor method) with 18 controls matched for sex, age and mean arterial pressure. Results: 69 urinary peptides had a different signal amplitude between cases and controls (P ≤ 0.049). Among 33 peptides with known sequence, 26 were members of the extracellular matrix family, including collagen type I α-1 and α-2, collagen type III α-1, collagen type IV α-5, collagens IX, XXI and XXVII. Collagen type I was down-regulated, whereas collagen type III was up-regulated. Epidermal growth factor receptor (EGFR), a key regulator of myoblast differentiation, and interactions of laminin with other proteins were down-regulated. Atherosclerosis signalling pathways and intrinsic prothrombin activation were the top pathways associated with increased PWV. Potential drug targets included collagen type IV α 3 and transforming growth factor β 3. Angiotensin-converting enzyme inhibitors, which are widely used for vascular protection, were among the possible therapeutic agents. Conclusions: We suggest that stiffening of large elastic arteries involves changes of the extracellular matrix, as reflected by collagen turnover and regulation of myoblast differentiation. Pathway analysis identified potential drug targets, possibly amenable by angiotensin-converting enzyme inhibition.https://www.atlantis-press.com/article/125930242/view |
| spellingShingle | Zhen-Yu Zhang Makis Izoidakis Wen-Yi Yang Lutgarde Thijs Fang-Fei Wei Qi-Fang Huang Joost Schanstra Jens-Uwe Voigt Tatiana Kuznetsova Peter Verhamme Antonia Vlahou Harald Mischak Jan Staessen P7 THE URINARY PEPTIDOMIC SIGNATURE OF AORTIC STIFFNESS REVEALS MOLECULAR PATHWAYS AND DRUG TARGETS Artery Research |
| title | P7 THE URINARY PEPTIDOMIC SIGNATURE OF AORTIC STIFFNESS REVEALS MOLECULAR PATHWAYS AND DRUG TARGETS |
| title_full | P7 THE URINARY PEPTIDOMIC SIGNATURE OF AORTIC STIFFNESS REVEALS MOLECULAR PATHWAYS AND DRUG TARGETS |
| title_fullStr | P7 THE URINARY PEPTIDOMIC SIGNATURE OF AORTIC STIFFNESS REVEALS MOLECULAR PATHWAYS AND DRUG TARGETS |
| title_full_unstemmed | P7 THE URINARY PEPTIDOMIC SIGNATURE OF AORTIC STIFFNESS REVEALS MOLECULAR PATHWAYS AND DRUG TARGETS |
| title_short | P7 THE URINARY PEPTIDOMIC SIGNATURE OF AORTIC STIFFNESS REVEALS MOLECULAR PATHWAYS AND DRUG TARGETS |
| title_sort | p7 the urinary peptidomic signature of aortic stiffness reveals molecular pathways and drug targets |
| url | https://www.atlantis-press.com/article/125930242/view |
| work_keys_str_mv | AT zhenyuzhang p7theurinarypeptidomicsignatureofaorticstiffnessrevealsmolecularpathwaysanddrugtargets AT makisizoidakis p7theurinarypeptidomicsignatureofaorticstiffnessrevealsmolecularpathwaysanddrugtargets AT wenyiyang p7theurinarypeptidomicsignatureofaorticstiffnessrevealsmolecularpathwaysanddrugtargets AT lutgardethijs p7theurinarypeptidomicsignatureofaorticstiffnessrevealsmolecularpathwaysanddrugtargets AT fangfeiwei p7theurinarypeptidomicsignatureofaorticstiffnessrevealsmolecularpathwaysanddrugtargets AT qifanghuang p7theurinarypeptidomicsignatureofaorticstiffnessrevealsmolecularpathwaysanddrugtargets AT joostschanstra p7theurinarypeptidomicsignatureofaorticstiffnessrevealsmolecularpathwaysanddrugtargets AT jensuwevoigt p7theurinarypeptidomicsignatureofaorticstiffnessrevealsmolecularpathwaysanddrugtargets AT tatianakuznetsova p7theurinarypeptidomicsignatureofaorticstiffnessrevealsmolecularpathwaysanddrugtargets AT peterverhamme p7theurinarypeptidomicsignatureofaorticstiffnessrevealsmolecularpathwaysanddrugtargets AT antoniavlahou p7theurinarypeptidomicsignatureofaorticstiffnessrevealsmolecularpathwaysanddrugtargets AT haraldmischak p7theurinarypeptidomicsignatureofaorticstiffnessrevealsmolecularpathwaysanddrugtargets AT janstaessen p7theurinarypeptidomicsignatureofaorticstiffnessrevealsmolecularpathwaysanddrugtargets |